Notably, a large-scale meta-analysis demonstrated that although the APOE ε4 allele confers generally a similar risk of developing AD in women and men aged 55–85 years, noteworthy differences can be found when stratifying patients by age groups (Neu et al., 2017). This evidence concerns the gene APOE and Alzheimer disease.